Skip to main content
Erschienen in: Diabetologia 1/2007

01.01.2007 | Article

High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study

verfasst von: L. Prompers, M. Huijberts, J. Apelqvist, E. Jude, A. Piaggesi, K. Bakker, M. Edmonds, P. Holstein, A. Jirkovska, D. Mauricio, G. Ragnarson Tennvall, H. Reike, M. Spraul, L. Uccioli, V. Urbancic, K. Van Acker, J. van Baal, F. van Merode, N. Schaper

Erschienen in: Diabetologia | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Large clinical studies describing the typical clinical presentation of diabetic foot ulcers are limited and most studies were performed in single centres with the possibility of selection of specific subgroups. The aim of this study was to investigate the characteristics of diabetic patients with a foot ulcer in 14 European hospitals in ten countries.

Methods

The study population included 1,229 consecutive patients presenting with a new foot ulcer between 1 September 2003 and 1 October 2004. Standardised data on patient characteristics, as well as foot and ulcer characteristics, were obtained. Foot disease was categorised into four stages according to the presence or absence of peripheral arterial disease (PAD) and infection: A: PAD −, infection −; B: PAD −, infection +; C: PAD +, infection −; D: PAD +, infection +.

Results

PAD was diagnosed in 49% of the subjects, infection in 58%. The majority of ulcers (52%) were located on the non-plantar surface of the foot. With regard to severity, 24% had stage A, 27% had stage B, 18% had stage C and 31% had stage D foot disease. Patients in the latter group had a distinct profile: they were older, had more non-plantar ulcers, greater tissue loss and more serious comorbidity.

Conclusions/interpretation

According to our results in this European cohort, the severity of diabetic foot ulcers at presentation is greater than previously reported, as one-third had both PAD and infection. Non-plantar foot ulcers were more common than plantar ulcers, especially in patients with severe disease, and serious comorbidity increased significantly with increasing severity of foot disease. Further research is needed to obtain insight into the clinical outcome of these patients.
Literatur
1.
Zurück zum Zitat Reiber GE, Vileikyte L, Boyko EJ et al (1999) Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 22:157–162PubMed Reiber GE, Vileikyte L, Boyko EJ et al (1999) Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 22:157–162PubMed
2.
Zurück zum Zitat Reiber GE, Lipsky BA, Gibbons GW (1998) The burden of diabetic foot ulcers. Am J Surg 176:5S–10SPubMedCrossRef Reiber GE, Lipsky BA, Gibbons GW (1998) The burden of diabetic foot ulcers. Am J Surg 176:5S–10SPubMedCrossRef
3.
Zurück zum Zitat Ragnarson Tennvall G, Apelqvist J (2004) Health–economic consequences of diabetic foot lesions. Clin Infect Dis 39(Suppl 2):S132–S139PubMedCrossRef Ragnarson Tennvall G, Apelqvist J (2004) Health–economic consequences of diabetic foot lesions. Clin Infect Dis 39(Suppl 2):S132–S139PubMedCrossRef
5.
Zurück zum Zitat Boulton AJ (2004) The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 47:1343–1353PubMedCrossRef Boulton AJ (2004) The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 47:1343–1353PubMedCrossRef
6.
Zurück zum Zitat Frykberg RG (2003) An evidence-based approach to diabetic foot infections. Am J Surg 186:44S–54S; discussion 61S–64SPubMedCrossRef Frykberg RG (2003) An evidence-based approach to diabetic foot infections. Am J Surg 186:44S–54S; discussion 61S–64SPubMedCrossRef
7.
Zurück zum Zitat Apelqvist J, Agardh CD (1992) The association between clinical risk factors and outcome of diabetic foot ulcers. Diabetes Res Clin Pract 18:43–53PubMedCrossRef Apelqvist J, Agardh CD (1992) The association between clinical risk factors and outcome of diabetic foot ulcers. Diabetes Res Clin Pract 18:43–53PubMedCrossRef
8.
Zurück zum Zitat Armstrong DG, Lavery LA, Harkless LB (1998) Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 21:855–859PubMed Armstrong DG, Lavery LA, Harkless LB (1998) Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 21:855–859PubMed
9.
Zurück zum Zitat Ramsey SD, Newton K, Blough D et al (1999) Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22:382–387PubMed Ramsey SD, Newton K, Blough D et al (1999) Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22:382–387PubMed
10.
Zurück zum Zitat Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA (2002) Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing. Diabetes Care 25:1835–1839PubMed Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA (2002) Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing. Diabetes Care 25:1835–1839PubMed
11.
Zurück zum Zitat Mueller MJ, Sinacore DR, Hastings MK, Strube MJ, Johnson JE (2003) Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial. J Bone Joint Surg Am 85-A:1436–1445PubMed Mueller MJ, Sinacore DR, Hastings MK, Strube MJ, Johnson JE (2003) Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial. J Bone Joint Surg Am 85-A:1436–1445PubMed
12.
Zurück zum Zitat Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ (2003) Predictive value of foot pressure assessment as part of a population-based diabetes disease management program. Diabetes Care 26:1069–1073PubMed Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ (2003) Predictive value of foot pressure assessment as part of a population-based diabetes disease management program. Diabetes Care 26:1069–1073PubMed
13.
Zurück zum Zitat Nabuurs-Franssen MH, Sleegers R, Huijberts MS et al (2005) Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. Diabetes Care 28:243–247PubMed Nabuurs-Franssen MH, Sleegers R, Huijberts MS et al (2005) Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. Diabetes Care 28:243–247PubMed
14.
Zurück zum Zitat Mueller MJ, Diamond JE, Sinacore DR et al (1989) Total contact casting in treatment of diabetic plantar ulcers. Controlled clinical trial. Diabetes Care 12:384–388PubMed Mueller MJ, Diamond JE, Sinacore DR et al (1989) Total contact casting in treatment of diabetic plantar ulcers. Controlled clinical trial. Diabetes Care 12:384–388PubMed
15.
Zurück zum Zitat Armstrong DG, Nguyen HC, Lavery LA, van Schie CH, Boulton AJ, Harkless LB (2001) Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 24:1019–1022PubMed Armstrong DG, Nguyen HC, Lavery LA, van Schie CH, Boulton AJ, Harkless LB (2001) Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 24:1019–1022PubMed
16.
Zurück zum Zitat Schaper NC (2004) Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 20(Suppl 1):S90–S95PubMedCrossRef Schaper NC (2004) Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 20(Suppl 1):S90–S95PubMedCrossRef
17.
Zurück zum Zitat Boulton AJ, Gries FA, Jervell JA (1998) Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med 15:508–514PubMedCrossRef Boulton AJ, Gries FA, Jervell JA (1998) Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med 15:508–514PubMedCrossRef
18.
Zurück zum Zitat Oyibo SO, Jude EB, Tarawneh I et al (2001) The effects of ulcer size and site, patient’s age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 18:133–138PubMedCrossRef Oyibo SO, Jude EB, Tarawneh I et al (2001) The effects of ulcer size and site, patient’s age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 18:133–138PubMedCrossRef
19.
Zurück zum Zitat Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJ (2001) A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care 24:84–88PubMed Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJ (2001) A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care 24:84–88PubMed
20.
Zurück zum Zitat Moulik PK, Mtonga R, Gill GV (2003) Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care 26:491–494PubMed Moulik PK, Mtonga R, Gill GV (2003) Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care 26:491–494PubMed
21.
Zurück zum Zitat Apelqvist J, Larsson J, Agardh CD (1990) The importance of peripheral pulses, peripheral oedema and local pain for the outcome of diabetic foot ulcers. Diabet Med 7:590–594PubMedCrossRef Apelqvist J, Larsson J, Agardh CD (1990) The importance of peripheral pulses, peripheral oedema and local pain for the outcome of diabetic foot ulcers. Diabet Med 7:590–594PubMedCrossRef
22.
Zurück zum Zitat Schaper NC, Nabuurs-Franssen MH (2002) The diabetic foot: pathogenesis and clinical evaluation. Semin Vasc Med 2:221–228PubMedCrossRef Schaper NC, Nabuurs-Franssen MH (2002) The diabetic foot: pathogenesis and clinical evaluation. Semin Vasc Med 2:221–228PubMedCrossRef
23.
Zurück zum Zitat Dormandy JA, Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 31:S1–S296PubMedCrossRef Dormandy JA, Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 31:S1–S296PubMedCrossRef
24.
Zurück zum Zitat Cavanagh PR, Lipsky BA, Bradbury AW, Botek G (2005) Treatment for diabetic foot ulcers. Lancet 366:1725–1735PubMedCrossRef Cavanagh PR, Lipsky BA, Bradbury AW, Botek G (2005) Treatment for diabetic foot ulcers. Lancet 366:1725–1735PubMedCrossRef
25.
Zurück zum Zitat Boyko EJ, Ahroni JH, Stensel VL, Smith DG, Davignon DR, Pecoraro RE (1996) Predictors of transcutaneous oxygen tension in the lower limbs of diabetic subjects. Diabet Med 13:549–554PubMedCrossRef Boyko EJ, Ahroni JH, Stensel VL, Smith DG, Davignon DR, Pecoraro RE (1996) Predictors of transcutaneous oxygen tension in the lower limbs of diabetic subjects. Diabet Med 13:549–554PubMedCrossRef
26.
Zurück zum Zitat Larsen K, Holstein P, Deckert T (1989) Limb salvage in diabetics with foot ulcers. Prosthet Orthot Int 13:100–103PubMed Larsen K, Holstein P, Deckert T (1989) Limb salvage in diabetics with foot ulcers. Prosthet Orthot Int 13:100–103PubMed
27.
Zurück zum Zitat Viswanathan V, Madhavan S, Gnanasundaram S et al (2004) Effectiveness of different types of footwear insoles for the diabetic neuropathic foot: a follow-up study. Diabetes Care 27:474–477PubMed Viswanathan V, Madhavan S, Gnanasundaram S et al (2004) Effectiveness of different types of footwear insoles for the diabetic neuropathic foot: a follow-up study. Diabetes Care 27:474–477PubMed
28.
Zurück zum Zitat Caravaggi C, De Giglio R, Pritelli C et al (2003) HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care 26:2853–2859PubMed Caravaggi C, De Giglio R, Pritelli C et al (2003) HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care 26:2853–2859PubMed
29.
Zurück zum Zitat Faglia E, Dalla Paola L, Clerici G et al (2005) Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg 29:620–627PubMedCrossRef Faglia E, Dalla Paola L, Clerici G et al (2005) Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg 29:620–627PubMedCrossRef
30.
Zurück zum Zitat Adam DJ, Beard JD, Cleveland T et al (2005) Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366:1925–1934PubMedCrossRef Adam DJ, Beard JD, Cleveland T et al (2005) Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366:1925–1934PubMedCrossRef
31.
Zurück zum Zitat Raymakers JT, Houben AJ, van der Heyden JJ, Tordoir JH, Kitslaar PJ, Schaper NC (2001) The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb. Diabet Med 18:229–234PubMedCrossRef Raymakers JT, Houben AJ, van der Heyden JJ, Tordoir JH, Kitslaar PJ, Schaper NC (2001) The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb. Diabet Med 18:229–234PubMedCrossRef
32.
Zurück zum Zitat Harkless L, Boghossian J, Pollak R et al (2005) An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. Surg Infect (Larchmt) 6:27–40CrossRef Harkless L, Boghossian J, Pollak R et al (2005) An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. Surg Infect (Larchmt) 6:27–40CrossRef
33.
Zurück zum Zitat Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA (2005) Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 366:1695–1703PubMedCrossRef Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA (2005) Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 366:1695–1703PubMedCrossRef
34.
Zurück zum Zitat Abbott CA, Carrington AL, Ashe H et al (2002) The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19:377–384PubMedCrossRef Abbott CA, Carrington AL, Ashe H et al (2002) The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19:377–384PubMedCrossRef
35.
Zurück zum Zitat Litzelman DK, Marriott DJ, Vinicor F (1997) Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care 20:1273–1278PubMed Litzelman DK, Marriott DJ, Vinicor F (1997) Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care 20:1273–1278PubMed
Metadaten
Titel
High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study
verfasst von
L. Prompers
M. Huijberts
J. Apelqvist
E. Jude
A. Piaggesi
K. Bakker
M. Edmonds
P. Holstein
A. Jirkovska
D. Mauricio
G. Ragnarson Tennvall
H. Reike
M. Spraul
L. Uccioli
V. Urbancic
K. Van Acker
J. van Baal
F. van Merode
N. Schaper
Publikationsdatum
01.01.2007
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 1/2007
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0491-1

Weitere Artikel der Ausgabe 1/2007

Diabetologia 1/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.